PRC1 and breast cancer: Conversely, MSC-derived sEVs-miR-139-5p inhibits BC development by targeting and downregulating cytokinesis 1 (PRC1), thereby suppressing BC cell proliferation and subsequent BC progression (Jia et al., 2021).